Fierce Healthcare

CMS launched TEAM, a mandatory bundled payment model for hospitals, on Jan. 1. We explore what’s at stake and what it signals for the future of value-based care.

Tech is core to Cityblock. The company already uses AI today, including to alleviate the admin burden for providers, but plans to invest more in R&D in the space.

The Trump administration has released a new update on enrollment on the Affordable Care Act's exchanges, with signups lagging notably behind figures for the 2025 plan year.

Between the slides on finance and strategy, CommonSpirit CEO Wright Lassiter spent a substantial portion of his J.P. Morgan Healthcare Conference talk outlining his and the system’s views on AI in healthcare.

SAN FRANCISCO—In a room filled with 200 health system and payer executives, along with digital health entrepreneurs, CMS Administrator Mehmet Oz, M.D., and his leadership team shared future plans following a year of rapid policy changes. It was also a recruitment pitch.

Trump administration healthcare leaders are making a big splash at this year's J.P. Morgan Healthcare Conference.

SAN FRANCISCO—Advances in agentic AI will enable a system of AI agents that can be subspecialists in clinical areas, OpenEvidence co-founder Daniel Nadler, Ph.D., said at the annual J.P. Morgan Healthcare Conference.

OpenAI acquired a healthcare startup that unifies lab results, medications and provider visit recordings as it builds out ChatGPT Health.

A new Senate report alleges that UnitedHealth Group aggressively sought diagnoses that could increase its payouts in Medicare Advantage.

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs.

The company is adding a slew of other capabilities, like in-visit consultations with board-certified specialists and real-time prescription drug benefit checks.

SAN FRANCISCO—2025 was a tale of two markets and a clear separation between the "haves" and "have-nots" as fewer companies are capturing this capital, Rock Health analysts noted. AI-native upstarts attracted huge rounds, but 35% of deals were flat or down rounds in 2025.

The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers and dealers to San Francisco.

SAN FRANCISCO—Hippocratic AI is building out its life sciences division to accelerate generative and agentic AI in the biopharma and medtech sectors.

SAN FRANCISCO—Health tech company Elation Health has embedded Anthropic's Claude into its electronic health record to power its AI-driven chart summaries.

Abridge is partnering with real-time health information network Availity to fire up AI-powered prior authorization, expanding the reach of real-time coverage approval to more providers.

Anthropic is pushing into the healthcare market as it launches artificial intelligence tools and resources purpose-built for providers and payers.

Redesign Health has launched more than 60 companies touching the lives of more than 15 million patients, and it's raised more than $1.5 billion from institutional, sovereign and strategic investors—all during a time of volatility in the venture market, massive disruptions to care delivery and shifts in policy.

Pittsburgh-based insurer Highmark is further expanding its drug offerings through CivicaScript and leaning on biosimilars as pharmaceutical costs continue to rise for many.

Deal volume was the second-highest on record, at 445 buyouts, as was the exit value at an expected $156 billion. Bain & Company predicts an active year ahead as portfolios mature and exit pipelines build.